Pomegranate Alternative for GLP-1 Users Who Want Daily Habit Tracking
MeAgain is the best Pomegranate alternative for GLP-1 users because it gives you one daily app for shots, meals, and symptoms, keeps pricing simple, and still offers an optional self-pay path inside the app. Pomegranate Health is a legitimate telehealth option with free consultation, no public membership requirement on weight loss, and live pricing that can be cheaper than MeAgain on medication-only cost. Its public semaglutide pricing spans about $109 to $199, and tirzepatide spans about $159 to $399, depending on pharmacy, state, and package length. If your only goal is the lowest medication price, Pomegranate can be the better fit. MeAgain wins on the part that starts after approval. The app keeps your weekly shot, food, water, protein, symptoms, weight, and progress in one place, then adds a guided weekly checklist, an injection site rotation map, a medication graph, and five food logging methods. MeAgain is trusted by 286,000 users and rated 4.8 stars across over 15,000 App Store ratings.
Key takeaways
- 1.Pomegranate's public flow offers free consultation and no membership requirement on weight loss, with live semaglutide and tirzepatide pricing that can beat MeAgain on medication-only cost. If you only want access, that matters. If you want a daily app too, MeAgain is the better fit.
- 2.MeAgain adds the tools you keep using after the consult: a guided weekly checklist, injection site rotation map, medication graph, five food logging methods, and a structured 20-symptom log tied to food, water, protein, and weight.
- 3.Trust looks different here. Pomegranate says it serves 100,000+ people. MeAgain is the GLP-1 app 286,000 users already rely on, with a 4.8-star App Store rating across over 15,000 ratings and medication shipped in 5-7 days after approval.
- 4.Pomegranate is broader telehealth with longevity, skin, hair, men's health, and women's health services alongside weight loss. MeAgain stays focused on the GLP-1 week so your shot, meals, hydration, symptoms, and progress stay together in one place.
- 5.Eligible subscribers can use MeAgain's in-app intake for semaglutide at $123/month or tirzepatide at $199/month through US-based 503A and 503B pharmacies. Pomegranate can still be cheaper on medication-only price, but MeAgain gives you the stronger daily app on top.
MeAgain vs Pomegranate: Access vs the Daily GLP-1 App
Pomegranate is the stronger pick if you mainly want telehealth access and the lowest medication-only price available on its public flow. MeAgain is the stronger pick if you want one daily GLP-1 app for the weekly shot, food, symptoms, hydration, weight, and progress, plus an optional self-pay path inside the app. That makes the tradeoff simple: access-first portal versus app-first daily support.
| Feature | MeAgain | Pomegranate |
|---|---|---|
| Guided weekly checklist with prep steps | ||
| Injection site rotation map | ||
| Medication graph | ||
| Structured 20-symptom log with 0-10 severity | ||
| Five direct food logging methods | ||
| Journey Cards | ||
| AI companion | ||
| Optional self-pay GLP-1 path | ||
| Licensed clinician review | ||
| Web onboarding and care dashboard | ||
| Broader telehealth categories beyond weight loss | ||
| No separate monthly fee on public weight-loss flow |
What Makes MeAgain a Better Pomegranate Alternative?
01Pomegranate Helps You Start. MeAgain Helps You Stay on Track.
Pomegranate's public experience is built to move you through intake, clinician review, pricing, and the care dashboard. That is useful if the main job is getting access. MeAgain is built for what happens next. It is the app you open when shot day is tomorrow, when food felt off today, or when you want to see whether nausea lined up with the timing of your last dose. The tracker keeps your weekly shot, meals, water, protein, symptoms, weight, and progress in one place, so the routine stays readable instead of scattered across notes and memory. That difference matters over long treatment timelines. In STEP-1, semaglutide users averaged 14.9% weight loss at 68 weeks across 1,961 adults. In SURMOUNT-1, tirzepatide users averaged 20.9% at 72 weeks across 2,539 adults. Over months like that, access is only the start. The bigger need is a daily system you keep using.
02A Better Home for Shot Day
MeAgain puts the weekly shot at the center of the product. The app gives you a guided weekly checklist with prep steps, a next-shot countdown, an injection site rotation map, and a medication graph across the week. That makes it easier to remember where you injected last time, see when symptoms tend to hit, and keep the rest of the week organized around the dose you actually took. Pomegranate's public site talks about fast turnaround, clinician review, and the care dashboard. Those are real strengths for access. But its public materials do not center the weekly shot workflow the way MeAgain does. For many GLP-1 users, that is where day-to-day confusion shows up first. A good telehealth company can help you get started. A better daily app helps you stay steady once you already have the medication in your fridge.
03Simple Pricing, Honest Tradeoffs
Pomegranate can be cheaper on medication-only price. Its public pricing changes by pharmacy, state, and package length, so there is no honest single number that fits every shopper. On the public flow, semaglutide can land around $109 to $199 and tirzepatide around $159 to $399, with no separate membership fee shown for weight loss. MeAgain is simpler to read: $9.99/month for the app, plus an optional in-app self-pay path at $123/month for semaglutide or $199/month for tirzepatide after licensed clinician approval. We make money from our $9.99/month app subscription. That's it. That is why MeAgain makes the most sense when you want the daily app, not when you are only shopping for the lowest medication price. The value is having food logging, shot day prep, the medication graph, injection tracking, and symptoms together in one place.
04Your Tracker Still Works if Your Prescription Source Changes
MeAgain's tracker is useful even if your prescription source changes. You can use it whether your medication comes from Pomegranate, MeAgain, insurance, another telehealth company, or a local doctor. That matters because many GLP-1 users do not stay with one source forever. They switch pharmacies, move from semaglutide to tirzepatide, pause treatment, or start again later. With MeAgain, your weekly shot history, meals, water, protein, symptoms, weight, and progress stay in one place while the prescription path changes around you. Pomegranate's public product is tied more closely to its own onboarding and care dashboard, which is normal for telehealth. MeAgain takes the opposite approach. The tracker stays useful first, and the in-app self-pay option sits inside it for eligible subscribers when they want it. That flexibility is hard to replace once the routine is already working.
Medication Access Is the Start. The Week After Still Needs a Home.
Pomegranate is a real telehealth option. Its public site says the process is 100% online, the consultation is free, turnaround is 3-5 business days, and the company is trusted by 100,000+ people. The live pricing also explains why many shoppers compare it closely: semaglutide spans about $109-$199 and tirzepatide about $159-$399 across different pharmacy, state, and package combinations. That can be cheaper than MeAgain when the only question is medication access. But GLP-1 treatment usually lasts much longer than the first approval screen. In STEP-1, semaglutide users averaged 14.9% weight loss at 68 weeks across 1,961 adults. In SURMOUNT-1, tirzepatide users averaged 20.9% at 72 weeks across 2,539 adults. Over timelines like that, most people need more than a care portal. They need one daily place for the shot, food, hydration, symptoms, and weight trend.
| Question | Pomegranate | MeAgain |
|---|---|---|
| Core experience | Broader telehealth service with web onboarding and care dashboard | Daily GLP-1 app plus optional self-pay path |
| Medication-only price shape | Public ranges vary by pharmacy, state, and package length | $123 semaglutide or $199 tirzepatide plus $9.99 app |
| Consultation structure | Free consultation, no separate monthly fee shown publicly | In-app intake with licensed clinician review for eligible subscribers |
| Daily app layer | Care dashboard is public; app-first GLP-1 layer is not | 286,000-user App Store app built for GLP-1 |
| Food and symptom layer | Not centered publicly | Five food logging methods plus a structured 20-symptom log |
| Weekly shot workflow | Not centered publicly | Checklist, countdown, site rotation, and medication graph |
| Broader health footprint | Weight loss, longevity, skin, hair, men's, and women's health | Focused on the GLP-1 routine |
| Best fit | People who mainly want telehealth access | People who want the daily GLP-1 app |
MeAgain makes money from the $9.99/month app subscription. That's it. Pomegranate's public model is different: free consultation, no membership requirement on weight loss, and medication pricing that changes with pharmacy, state, and package length. That setup can be cheaper when medication-only cost is your main filter. MeAgain is built around a different promise: a daily GLP-1 app that makes the week easier to follow after treatment begins. You pay for the tracker, then decide whether you also want the optional self-pay path inside it. The result is better day-to-day support, not a universal price win. And whichever medication your doctor keeps you on, the tracker works for it and the in-app intake is available inside MeAgain for eligible subscribers.
This content is for informational purposes only and does not constitute medical advice. Competitor pricing and features are based on publicly available information verified on April 8, 2026 and may change. Always consult your doctor about GLP-1 medications.
Sources
- Pomegranate weight-loss page
- Pomegranate onboarding and pricing page
- Pomegranate live GLP pricing configuration API
- Pomegranate onboarding app metadata and FAQ
- Pomegranate subscription terms
- Pomegranate BBB business profile
- Wilding JPH et al. - Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1, NEJM 2021, n=1,961)
- Jastreboff AM et al. - Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, n=2,539)
Why Pomegranate Searchers Still Pick a Daily GLP-1 App
Access Matters. So Does the App You Open Every Day.
Pomegranate can solve the access step. What many shoppers still want is a daily app once treatment starts. As one App Store reviewer, rbdpr, wrote on April 5, 2026: “MeAgain makes it super easy to track shots, medicine levels, protein and fiber intake, hydration, steps/movement, etc. I'm enjoying seeing my progress on my Home Screen and chatting with Capy when I want to brainstorm something related to my wellness journey.” That is the difference between a care portal and a daily routine app. When the box arrives, the job is not over. You still need one place to track the weekly shot, food, symptoms, and progress without rebuilding the system every week.
Pomegranate can be the better pick when the goal is medication-only access at the lowest public price. MeAgain is the stronger choice when you want the daily GLP-1 app too: shots, meals, hydration, symptoms, weight, and progress in one place, backed by 286,000 users and a 4.8-star App Store rating across over 15,000 ratings.
What Our Users Say
“I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication. The little capybara widget is a great visual to help me know what my body needs.”
“The Me Again app has been super helpful for managing my Wegovy journey. I love the reminder features and how easy it is to change the units — those tools make staying on track so much easier.”
“I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else. The app is totally worth the cost and it's been perfect for me.”
“I've been on my MJ journey since September 2025. Seeing my food intake has made a huge difference. Also, reviewing my shot locations has helped me remember to rotate. I have recommended this app to my friends who have also started their own journeys!”
“I honestly really like this app! It has been very useful in helping me track my protein and water while on tirzepatide. I love the cutie capybara I have to take care of every day, it's motivating!”
Pomegranate Alternative - FAQs
Yes. MeAgain is a strong Pomegranate alternative if you want a daily GLP-1 app, not just a telehealth company that handles intake and prescriptions. Pomegranate's public weight-loss flow has real strengths: free consultation, a 100% online process, no public membership requirement on weight loss, and medication pricing that can beat MeAgain on medication-only cost. MeAgain is better at a different part of the experience. The app keeps your weekly shot, food, water, protein, symptoms, and weight trend in one place, then adds the guided weekly checklist, injection site rotation map, the medication graph, and five food logging methods. That makes the ordinary week easier to understand instead of leaving you to piece it together after the prescription is approved. If your main goal is the lowest medication price, Pomegranate may fit better. If you want the stronger daily GLP-1 app once treatment starts, MeAgain is the better choice.
Your Journey Back to You,
One Day at a Time
Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.